China Pharmaceutical Packaging Industry Report, 2019-2025
  • May 2019
  • Hard Copy
  • USD $2,600
  • Pages:130
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: ZLC079
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,600
  • Hard Copy + Single User License
  • USD $2,800

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018, up to RMB107.4 billion, and it will be at least RMB200 billion in 2025 under the impetus of population aging, two-child policy, the boom of biological agents and related favorable policies.

In China, the high-end pharmaceutical packaging market is currently carved up by multinational corporations, typically BD, Gerresheimer, SCHOTT, Nipro and Amcor; Chinese companies just focus on low- and mid-end markets, but they tend to move toward the high-end by lavishing more on research and development as pharmaceutical packaging standards grow stricter.

A total of over 1,500 Chinese pharmaceutical packaging companies fall into three kinds: a handful of pharmaceutical giants that concentrate on independent production, like Sichuan Kelun Pharmaceutical Co., Ltd.; players which not only work on pharmaceutical packaging but have offerings for food, healthcare products and consumer goods packaging, such as Shandong Linuo Technical Glass Co., Ltd., Heilongjiang Tongyu Pharmaceutical Packaging Co., Ltd. and Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.; and those committing themselves to the R&D, production and sales of pharmaceutical packaging materials, for instance, Shandong Pharmaceutical Glass Co., Ltd., Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd., Shanxi Hongguang Medicine Packaging Co., Ltd. and Hebei First Rubbebr Medical Technology Co., Ltd.. In the lowly concentrated pharmaceutical packaging market of China, even the pharmaceutical glass bellwether Shandong Pharmaceutical Glass Co., Ltd. takes a tiny share of 2.4% in 2018. 


China’s pharmaceutical packaging industry holds the following trends:

1. New types of pharmaceutical packaging materials emerge.
China has built a standard system for pharmaceuticals industry over the years. The country pays more and more attention to the stability of pharmaceutical packaging materials during the drug storage period, and safety when used. Under this background, new types of green, degradable and easy-to-use pharmaceutical packaging materials and vessels are in the palmy days.

2. The industry is becoming more concentrated.
Mergers and acquisitions among pharmaceutical packaging companies occurred frequently in recent years, thanks to favorable policies like the Guidance on Accelerating the Merger and Reorganization of Enterprises in Key Industries. For instance, Shandong Pharmaceutical Glass Co., Ltd. acquired Sichuan Mianzhu Chengxin Pharmaceutical Glass Co. Ltd.; Anhui BBCA Pharmaceutical Co., Ltd. acquired Chengdu PUSH Pharmaceutical Co., Ltd.; China Jianyin Investment Ltd. (JIC) acquired SGD Pharma; and Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd. acquired Nanchong Sanying Medicinal Packaging Material Co., Ltd., Accordingly, Chinese pharmaceutical packaging market is increasingly concentrated.

3. Neutral borosilicate products substitute for low borosilicate products.
As people lead a better life, they require better quality of pharmaceutical packaging materials. A growing number of companies have applied international standard-based neutral borosilicate glass. Several companies including Shandong Pharmaceutical Glass Co., Ltd., Chongqing Zhengchuan Glass Co., Ltd., Cangzhou Four Stars Glass Co., Ltd., Anhui Huaxin Medicinal Glass Products Co., Ltd., Baoji Tongli Pharmaceutical Glass Co., Ltd. and Ningbo Zhengli Pharmaceutical Packing Co., Ltd. have been approved to roll out their neutral borosilicate glass products. Driven by companies that have passed consistency evaluation, neutral borosilicate products will become an alternative to low borosilicate products in China. The injection packaging materials field alone will see RMB3 billion to RMB9 billion be replaced.

China Pharmaceutical Packaging Industry Report, 2019-2025 highlights the following:
20120114.gifChina pharmaceutical packaging industry (development status, market size, competitive pattern, import & export, market segments, downstream demand, and development trend);
20120114.gif4 foreign companies (operation, pharmaceutical packaging business, and development in China);
20120114.gif16 Chinese companies (operation, pharmaceutical packaging business, and forecast).

1 Overview
1.1 Definition
1.2 Classification
1.3 Industry Chain

2 Chinese Pharmaceutical Packaging Industry
2.1 Status Quo
2.2 Market Size
2.3 Competitive Landscape
2.3.1 Foreign Companies
2.3.2 Chinese Companies
2.4 Import & Export
2.4.1 Import
2.4.2 Export
2.4.3 Comparison between Unit Prices of Imports and Exports
2.5 Market Segments
2.5.1 Medicinal Glass Packaging
2.5.2 Medicinal Plastic Packaging
2.5.3 Medicinal Rubber Packaging
2.5.4 Composite Packaging Materials
2.6 Downstream Demand
2.6.1 Vaccine
2.6.2 Blood Product
2.6.3 Insulin
2.6.4 Heparin
2.7 Development Trends
2.7.1 Population Aging and Two-child Policy Conduce to the Development of Pharmaceutical Industry
2.7.2 Favorable Policies Promote the Development of Pharmaceutical Packaging Industry
2.7.3 Rapid Development of Biological Agents is in Favor of Pharmaceutical Packaging Industry
2.7.4 Neutral Borosilicate Pharmaceutical Glass Tube Will Substitute for Low Borosilicate Products Gradually
2.7.5 New Pharmaceutical Packaging Materials Grow Up
2.7.6 Pharmaceutical Packaging Industry Concentration Gets Improved Further
2.7.7 Injection Packaging Materials Tend to be Neutral Borosilicate 

3 Foreign Companies
3.1 Becton, Dickinson and Company
3.1.1 Profile
3.1.2 Operation
3.1.3 Revenue Structure
3.1.4 Pharmaceutical Packaging Business
3.1.5 Development in China
3.2 Gerresheimer AG
3.2.1 Profile
3.2.2 Operation
3.2.3 Revenue Structure
3.2.4 Pharmaceutical Packaging Business
3.2.5 Development in China
3.3.1 Profile
3.3.2 Operation
3.3.3 Pharmaceutical Packaging Business
3.3.4 Development in China
3.4 Nipro Medical Corporation
3.4.1 Profile
3.4.2 Operation
3.4.3 Revenue Structure
3.4.4 Pharmaceutical Packaging Business
3.4.5 Development in China

4 Chinese Companies
4.1 Shandong Pharmaceutical Glass Co., Ltd.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R&D and Investment
4.1.6 Development Strategy
4.2 Sichuan Kelun Pharmaceutical Co., Ltd.
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 R&D and Investment
4.2.5 Pharmaceutical Packaging Business
4.2.6 Development Strategy
4.3 Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 Pharmaceutical Packaging Business
4.3.6 Development Strategy
4.4 Shandong Weigao Group Medical Polymer Co., Ltd (WEGO)
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 R&D and Investment
4.4.5 Pharmaceutical Packaging Business
4.4.6 Development Strategy
4.5 Hongguang Medicine Packaging Company
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Major Customers
4.5.5 Pharmaceutical Packaging Business
4.5.6 Development Strategy
4.6 Tongyu Pharmaceutical Packaging Co., Ltd.
4.6.1 Profile
4.6.2 Operation
4.6.3 Major Customers
4.6.4 Gross Margin
4.6.5 Pharmaceutical Packaging Business
4.6.6 Development Strategy
4.7 Linuo Glassworks Group
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 Major Customers
4.7.6 Pharmaceutical Packaging Business
4.7.7 Development Strategy
4.8 Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Major Customers
4.8.5 Pharmaceutical Packaging Business
4.8.6 Development Strategy
4.9 Chongqing Zhengchuan Glass Co., Ltd
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Pharmaceutical Packaging Business
4.9.5 Development Strategy
4.10 Hebei First Rubber Medical Technology Co., ltd
4.10.1 Profile
4.10.2 Operation
4.10.3 Revenue Structure
4.10.4 Pharmaceutical Packaging Business
4.10.5 Development Strategy
4.11 J.S. Yunkang Officinal Package Co., Ltd
4.11.1 Profile
4.11.2 Pharmaceutical Packaging Business
4.12 Shanghai Jiatian Pharmaceutical Packaging Co., Ltd
4.12.1 Profile
4.12.2 Pharmaceutical Packaging Business
4.13 Cangzhou four stars glass co., ltd.
4.13.1 Profile
4.13.2 Pharmaceutical Packaging Business
4.14 Lindu yao yong bao zhuang
4.14.1 Profile
4.14.2 Pharmaceutical Packaging Business
4.15 Global Printing
4.15.1 Profile
4.15.2 Operation
4.15.3 Revenue Structure
4.15.4 Pharmaceutical Packaging Business
4.15.5 Development Strategy
4.16 Jiangsu Hualan New Pharmaceutical Material Co., Ltd.
4.16.1 Profile
4.16.2 Pharmaceutical Packaging Business
Advantages and Disadvantages of Different Pharmaceutical Packaging Materials
Classification of Pharmaceutical Packaging Materials in China
Pharmaceutical Packaging Industry Chain
China’s Pharmaceutical Packaging Market Size, 2010-2018
China’s Pharmaceutical Packaging Market Size, 2015-2021E
Classification of Pharmaceutical Packaging Materials Producers in China
Revenue Comparison of Major Pharmaceutical Packaging Enterprises in China, 2013-2018
Net Income Comparison of Major Pharmaceutical Packaging Enterprises in China, 2013-2018
China’s Import Volume and Import Value of Glass Ampoules, 2011-2016
China’s Top 10 Glass Ampoule Importing Countries/Regions, 2016
China’s Export Volume and Export Value of Glass Ampoules, 2011-2016
China’s Top 10 Glass Ampoule Exporting Countries/Regions, 2016
China’s Average Import/Export Price of Glass Ampoules, 2011-2016
New Pharmaceutical Glass Packaging and Applications
Classification and Performance Comparison of Pharmaceutical Glass
Profile of Major Pharmaceutical Glass Enterprises in China
Performance Comparison of PVC/PVDC and PVC Materials
Profile of Major Pharmaceutical Plastic Packaging Production Enterprises in China
Profile of Major Pharmaceutical Rubber Packing Material Production Enterprises in China
Lot Release Volume and YoY Growth of Human Vaccine in China, 2013-2018
Top 10 Human Vaccines by Lot Release Volume in China, 2013-2018
Human Vaccine Varieties and Manufacturers Approved for Lot Release in China, Jan-Sept 2018
Human Vaccine Market Size and YoY Growth in China, 2010-2018
Vaccine Market Size in China, 2017-2025E
Lot Release Volume of Main Blood Products in China, 2014-2018
Comparison between Price with Limit Removed and Previous Maximum Retail Price of Blood Products
Blood Products Market Size in China, 2010-2018
Blood Products Market Size in China, 2018-2025E 
China’s Insulin Drug Market Size, 2007-2018
China’s Insulin Drug Market Size, 2015-2025E
China’s Heparin Preparations Market Size, 2007-2018
China’s Heparin Preparations Market Size, 2015-2025E
Population of 60-Year-Old and Older in China, 2015-2025E
Policies on China Pharmaceutical Packaging Industry, 2012-2018
Total Output Value of China Biopharmaceutical Industry, 2008-2018
Total Output Value of China Biopharmaceutical Industry, 2016-2025E
Policies Pushed by the Chinese Government on Using First Grade Waterproof Neutral Borosilicate Glass
Major M&A Events in China Pharmaceutical Packaging Industry, 2014-2018
Injection Glass Packaging Material Market Size Estimation Framework
Product Mix of Main Injection Glass Packaging Material Companies
Volume of Neutral Borosilicate Glass Packaging Materials Downstream Injection Manufacturers Have Indicated to Use
Comparison between Unit Prices of Glass Vials for Injection
Estimated Injection Glass Packaging Material Market Size in China, 2012-2018
Ratio of Number of Generic Drugs to Price of Reference Listed Drugs
Pharmaceutical Companies Needing to Pass Consistency Evaluation and Statistics of Their Product Varieties 
Output of Injections outside the Scope of Consistency Evaluation, 2016 (1,000 Vials)
Oral Solid Dosage Form Passing Consistency Evaluation and Total Revenue from the Sample for Hospitals
Revenue from Powder/Liquid Injection Samples for Hospitals (RMB1,000) and % of Total Revenue
Consistency Evaluation Rules for Oral Solid Dosage Form: Formulated to Eliminate Generic Drugs not Subject to Consistency Evaluation
Pharmaceuticals Market Channel Structure in China  
Number of Injection Varieties Companies Have Applied for Consistency Evaluation as of 2018
Specifications Expected to be Disqualified from Centralized Procurement after Consistency Evaluation
Identification Analysis Data of Glass Packaging Materials for 58 Reference Listed Drugs (Targeting Powder Injection) 
Room for Injection Glass Packaging Materials Industry to Grow under Consistency Evaluation 
Ranking of Powder Injection Samples for Hospitals by Revenue and Sales Structure of Corresponding Varieties (Molded Vial + Tube-type Vial)
Ranking of Liquid Injection Samples for Hospitals by Revenue and Sales Structure of Corresponding Varieties (Glass Ampoule)  
Key Operations of BD
Revenue and Net Income of BD, FY2012-FY2018
Revenue Breakdown of BD by Segment, FY2018
Revenue Breakdown of BD’s Medical Segment by Business, FY2014-FY2018
Revenue Breakdown of BD’s Life Sciences Segment by Business, FY2014-FY2018
Revenue Breakdown of BD by Region, FY2014-FY2018
Revenue Structure of BD by Region, FY2014-FY2018
Revenue and Net Income of Gerresheimer, 2013-2018
Revenue Breakdown of Gerresheimer by Segment, 2013-2018
Revenue Structure of Gerresheimer by Segment, 2013-2018
Revenue Breakdown of Gerresheimer by Region, 2013-2018
Revenue Structure of Gerresheimer by Region, 2013-2018
Gerresheimer’s Main Pharmaceutical Packaging Products
Operating Results of SCHOTT, FY2015-FY2018
Distribution of SCHOTT’s Pharmaceutical Packaging Production Bases
SCHOTT’s Main Pharmaceutical Packaging Products
Global Presence of Nipro Medical
Revenue and Net Income of Nipro Medical, FY2013-FY2018
Revenue Breakdown of Nipro Medical by Product, FY2018
Revenue Structure of Nipro Medical by Product, FY2018
Revenue Breakdown of Nipro Medical by Region, FY2014-FY2018
Nipro Medical’s Revenue from Glass-related Business, FY2013-FY2018
Revenue Structure of Nipro Medical’s Glass-related Business by Region, FY2018
Nipro Medical’s Subsidiaries in China and Their Main Businesses
Main Products of Shandong Pharmaceutical Glass Co., Ltd.
Revenue and Net Income of Shandong Pharmaceutical Glass Co., Ltd., 2013-2018
Revenue Breakdown of Shandong Pharmaceutical Glass Co., Ltd. by Product, 2013-2018
Revenue Structure of Shandong Pharmaceutical Glass Co., Ltd. by Product, 2013-2018
Revenue Breakdown of Shandong Pharmaceutical Glass Co., Ltd. by Region, 2013-2018
Revenue Structure of Shandong Pharmaceutical Glass Co., Ltd. by Region, 2013-2018
Gross Margin of Shandong Pharmaceutical Glass Co., Ltd., 2013-2018
Gross Margin of Shandong Pharmaceutical Glass Co., Ltd. by Product, 2013-2018
Private Placement Subscription of Shandong Pharmaceutical Glass Co., Ltd., 2016
Private Placement and Fundraising Projects of Shandong Pharmaceutical Glass Co., Ltd., 2016
Revenue and Net Income of Sichuan Kelun Pharmaceutical Co., Ltd., 2013-2018
Revenue Breakdown of Sichuan Kelun Pharmaceutical Co., Ltd. by Product, 2013-2018
Revenue Structure of Sichuan Kelun Pharmaceutical Co., Ltd. by Product, 2013-2018
Revenue Breakdown of Sichuan Kelun Pharmaceutical Co., Ltd. by Region, 2013-2018
Revenue Structure of Sichuan Kelun Pharmaceutical Co., Ltd. by Region, 2013-2018
R&D Costs of Sichuan Kelun Pharmaceutical Co., Ltd., 2013-2018
Specifications of Marketed Pharmaceutical Packaging Products of Sichuan Kelun Pharmaceutical Co., Ltd.
Specifications of Upcoming Pharmaceutical Packaging Products of Sichuan Kelun Pharmaceutical Co., Ltd.
Revenue and Net Income of Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd., 2013-2018
Revenue Breakdown of Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd. by Product, 2014-2018
Gross Margin of Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd., 2013-2018
Main Products of Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd.
Product Categories and Main Products of Shandong Weigao Group Medical Polymer Co., Ltd.
Revenue and Net Income of Shandong Weigao Group Medical Polymer Co., Ltd., 2013-2018
Revenue Breakdown of Shandong Weigao Group Medical Polymer Co., Ltd. by Region, 2013-2018
Revenue Structure of Shandong Weigao Group Medical Polymer Co., Ltd. by Region, 2013-2018
Revenue Breakdown of Shandong Weigao Group Medical Polymer Co., Ltd. by Product, 2013-2018
Revenue Structure of Shandong Weigao Group Medical Polymer Co., Ltd. by Product, 2013-2018
R&D Costs of Shandong Weigao Group Medical Polymer Co., Ltd., 2010-2018
Number of Patents of Shandong Weigao Group Medical Polymer Co., Ltd., 2007-2018
Shandong Weigao Group Medical Polymer Co., Ltd.’s Revenue from Pharmaceutical Packaging Business, 2013-2018
Development Course of Hongguang Medicine Packaging Company
Revenue and Net Income of Hongguang Medicine Packaging Company, 2014-2018
Revenue Breakdown of Hongguang Medicine Packaging Company by Product, 2014-2018
Hongguang Medicine Packaging Company’s Revenue from Top5 Clients, 2014-2018
Hongguang Medicine Packaging Company’s Sales Contracts with Amount over RMB1 Million, 2014-2018
Main Products of Hongguang Medicine Packaging Company
Production Process of First Grade Water-fast Pharmaceutical Glass Tubes of Hongguang Medicine Packaging Company
Production Process of First Grade Water-fast Ampoules of Hongguang Medicine Packaging Company
Revenue and Net Income of Tongyu Pharmaceutical Packaging Co., Ltd., 2013-2018
Tongyu Pharmaceutical Packaging Co., Ltd.’s Revenue from Top5 Clients, 2014-2018
Gross Margin of Tongyu Pharmaceutical Packaging Co., Ltd., 2013-2018
Pharmaceutical Packaging and Related Products of Tongyu Pharmaceutical Packaging Co., Ltd.
Revenue and Net Income of Linuo Glassworks Group, 2013-2018
Revenue Breakdown of Linuo Glassworks Group by Product, 2013-2015
Revenue Structure of Linuo Glassworks Group by Product, 2013-2015
Gross Margin of Linuo Glassworks Group, 2013-2018
Linuo Glassworks Group’s Revenue from Top5 Clients, 2013-2015
Pharmaceutical Packaging Products of Linuo Glassworks Group
Revenue and Net Income of Shanghai Haishun New Pharmaceutical Packaging Co., Ltd., 2013-2018
Revenue Breakdown of Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. by Product, 2014-2018
Revenue Structure of Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. by Product, 2014-2018
Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.’s Revenue from Top5 Clients, 2013-2015
Classification of Pharmaceutical Packaging Products of Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.
Fundraising Projects of Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.
Revenue and Net Income of ChongQing ZhengChuan Glass, 2014-2018
Revenue Breakdown of ChongQing ZhengChuan Glass by Product, 2014-2018
Revenue Structure of ChongQing ZhengChuan Glass by Product, 2014-2018
Classification of Pharmaceutical Packaging Products of ChongQing ZhengChuan Glass
Revenue and Net Income of First Rubber Medical, 2015-2018
Revenue Breakdown of First Rubber Medical by Product, 2015-2018
Revenue Structure of First Rubber Medical by Product, 2015-2018
Classification of Pharmaceutical Packaging Products of First Rubber Medical
Revenue and Net Income of First Rubber Medical, 2011-2018
Revenue Breakdown of First Rubber Medical by Product, 2011-2018
Revenue Structure of First Rubber Medical by Product, 2011-2018
Classification of Pharmaceutical Packaging Products of First Rubber Medical

China Contract Research Organization (CRO) Industry Report, 2020-2026

The contract research organization (CRO) industry has been galloping amid the global pharmaceutical market steadily in head way, the vibrant financing in the medical and health sector, and the prolife...

China Human Vaccine Industry Report, 2020-2026

In China, the lot release for human vaccines plunged by 17.7% in 2018 when the production record fraud of rabies vaccines for human use, freeze-dried by Changsheng Bio-Technology was exposed. The impa...

China Pharmaceutical Distribution Industry Report, 2019-2026

The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmace...

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号